Psychoactive Substance Use and Its Association with Mental Health Symptomatology Among Latvian Medical Students: A Cross-Sectional Study
International Journal of Environmental Research and Public Health · 2025
DOI: 10.3390/ijerph22121806 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Environmental Research and Public Health, 2025. Verfasst von Warnakulasuriya S A V Fernando und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Riga Stradiņš University, LV-1046 Riga, Latvia. Hauptthemen laut MEDLINE: Students, Medical, Substance-Related Disorders, Depression, Mental Health. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Riga Stradiņš University.
Abstract (Originalsprache)
Medical students are at elevated risk for psychoactive substance use and mental health challenges due to academic pressures and environmental stressors. This study aimed to determine the prevalence and trends of psychoactive substance use among medical students at Riga Stradins University (RSU) and to examine associations with symptoms of anxiety, depression, and resilience to stress. A bilingual, anonymous cross-sectional study was conducted using a SurveyMonkey-hosted questionnaire. The survey included a socio-demographic questionnaire, the Generalized Anxiety Disorder Questionnaire-7 (GAD-7), the Patient Health Questionnaire-9 (PHQ-9), the Brief Resilience Scale (BRS), and the World Health Organization Alcohol, Smoking, and Substance Involvement Screening Test (WHO ASSIST V3.1). A total of 559 RSU medical students participated (response rate: 31.8%). Lifetime substance use prevalence was highest for caffeine 98.7%, alcohol 93.9%, tobacco 68.4%, and cannabis 50.9%. High-risk use was noted for tobacco 6.8%, inhalants 4.2%, cocaine 3.6%, and alcohol 1.4%. Significant differences in total substance use were observed by gender (p = 0.006) and depression symptom severity by PHQ-9 (p < 0.001), which were predictors of the total involvement score. The findings suggest that further attention to mental health and substance use patterns among medical students may be beneficial for student well-being and professional development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Riga Stradiņš University, LV-1046 Riga, Latvia.
- Department of Psychosomatic Medicine and Psychotherapy, Riga Stradiņš University, LV-1046 Riga, Latvia.
- Department of Neuromedicine and Neurosciences, Faculty of Medicine and Life Sciences, University of Latvia, LV-1586 Riga, Latvia.
- Department of Psychiatry and Narcology, Riga Stradiņš University, LV-1005 Riga, Latvia.
ORCID-Profile: Warnakulasuriya S A V Fernando, Aviad David, Nicolo Cianci, Anastasija Sevcenko, Elmars Rancans, Lubova Renemane
Förderung
- Riga Stradiņš University
Zitieren
APA
Fernando, W. S. A. V., David, A., Cianci, N., Sevcenko, A., Vrublevska, J., Rancans, E., & Renemane, L. (2025). Psychoactive Substance Use and Its Association with Mental Health Symptomatology Among Latvian Medical Students: A Cross-Sectional Study. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph22121806
Vancouver
Fernando WSAV, David A, Cianci N, Sevcenko A, Vrublevska J, Rancans E, et al. Psychoactive Substance Use and Its Association with Mental Health Symptomatology Among Latvian Medical Students: A Cross-Sectional Study. International Journal of Environmental Research and Public Health. 2025. doi:10.3390/ijerph22121806
BibTeX
@article{Fernando2025,
author = {Fernando, Warnakulasuriya S A V and David, Aviad and Cianci, Nicolo and Sevcenko, Anastasija and Vrublevska, Jelena and Rancans, Elmars and Renemane, Lubova},
title = {Psychoactive Substance Use and Its Association with Mental Health Symptomatology Among Latvian Medical Students: A Cross-Sectional Study},
journal = {International Journal of Environmental Research and Public Health},
year = {2025},
doi = {10.3390/ijerph22121806}
}
EUVIMED